Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
SITUATION: A worker notifies management that he can't comply with hospital policy requiring all workers to get…
From - G2 Compliance Advisor
In the cyber age, protecting your lab from the potential threat posed by employee blogging, tweeting, Instagramming and…
From - G2 Compliance Advisor
Compliance managers of lab involved in the $3 billion consumer-based genetic testing business need to safeguard their flank against a growing legal risk…
From - G2 Compliance Advisor
Safeguarding personal health information (PHI) data from hackers, identity thieves and other cyber threats isn't just a legal obligation but…
From - G2 Compliance Advisor
No! No! No! The truth is that state laws on marijuana use and possession have little to no direct impact on workplace drug policies and the testing methods used…
From - G2 Compliance Advisor
Although the 2018 market-based Clinical Laboratory Fee Schedule (CLFS) is officially in effect, implementation of the new…
From - G2 Compliance Advisor
Although not officially a pandemic, the 2018 flu season has been the worst in nearly a decade. So why not use it as an opportunity to review your lab's pandemic preparations…
From - G2 Compliance Advisor
Bottom Line on Top: Yes, a mandatory flu vaccination policy is legally justifiable as long as…